TapewireFind a company

person · Reporting owner

Baird Melissa

Disclosed activity across 1 company

Tapewire entity
79881
SEC CIK
0001837815

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Hims & Hers Health, Inc.HIMS · Entity 1878Chief Operating OfficerMay 12, 2025May 13, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Hims & Hers Health, Inc.

Report date May 12, 2025 · Filed May 13, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect805,083 Ending reported balance After 2025-05-12 transaction · row 5
5 source rows · reconciled sequence

Row 1 · 2025-05-12 · Exercise / conversion · Acquired 33,333 · Balance 838,416

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

Row 2 · 2025-05-12 · Sale · Disposed 13,786 · Balance 824,630

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Row 3 · 2025-05-12 · Sale · Disposed 6,801 · Balance 817,829

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

F3: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Row 4 · 2025-05-12 · Sale · Disposed 7,556 · Balance 810,273

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

F4: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Row 5 · 2025-05-12 · Sale · Disposed 5,190 · Balance 805,083

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

F5: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.43 · Expires 2030-05-13Direct693,795 Reported balance After 2025-05-12 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2025-05-12 · Exercise / conversion · Disposed 33,333 · Balance 693,795

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

F6: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.

Filing footnotes · ownership attribution and instrument terms

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F4: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F5: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F6: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 15, 2023 Filed Sep 19, 2023 14:05 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 20,683 $6.31 $130,509.73
Disclosure

SEC source: 0001773751-23-000244 · wk-form4_1695146704.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 431,248

F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 14:05 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 52,579 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-23-000244 · wk-form4_1695146704.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 451,931

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
September 06, 2023 Filed Sep 6, 2023 19:48 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $6.87 $62,729.10
Disclosure

SEC source: 0001773751-23-000232 · wk-form4_1694044071.xml · nonDerivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 399,352

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $6.775 - $6.93. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 05, 2023 Filed Sep 6, 2023 19:48 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $6.80 $62,135.45
Disclosure

SEC source: 0001773751-23-000232 · wk-form4_1694044071.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 408,485

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $6.65 - $6.925. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 01, 2023 Filed Sep 6, 2023 19:48 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $6.87 $62,740.06
Disclosure

SEC source: 0001773751-23-000232 · wk-form4_1694044071.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 417,618

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $6.78 - $6.92. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 07, 2023 Filed Aug 8, 2023 16:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $8.00 $73,052.13
Disclosure

SEC source: 0001773751-23-000209 · wk-form4_1691526151.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 426,751

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $7.85 - $8.35. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 16:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $8.18 $74,731.69
Disclosure

SEC source: 0001773751-23-000206 · wk-form4_1691439739.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 435,884

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.055 - $8.255. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 16:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $8.26 $75,468.72
Disclosure

SEC source: 0001773751-23-000206 · wk-form4_1691439739.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 445,017

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.190 - $8.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 06, 2023 Filed Jul 10, 2023 16:17 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 9,133 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-23-000195 · wk-form4_1689020229.xml · derivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 841,687

Underlying: Class A Common Stock · 9,133 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
July 06, 2023 Filed Jul 10, 2023 16:17 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $8.68 $79,282.66
Disclosure

SEC source: 0001773751-23-000195 · wk-form4_1689020229.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 454,150

F1 · shares: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.595 - $8.735. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 06, 2023 Filed Jul 10, 2023 16:17 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 9,133 $0.40 $3,653.20
Disclosure

SEC source: 0001773751-23-000195 · wk-form4_1689020229.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 463,283

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

Read SEC document
July 05, 2023 Filed Jul 6, 2023 16:44 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 9,133 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-23-000193 · wk-form4_1688676266.xml · derivative · entry 6

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 850,820

Underlying: Class A Common Stock · 9,133 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
July 05, 2023 Filed Jul 6, 2023 16:44 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $8.88 $81,113.83
Disclosure

SEC source: 0001773751-23-000193 · wk-form4_1688676266.xml · nonDerivative · entry 4

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 454,150

F1 · shares: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.705 - $9.06. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 05, 2023 Filed Jul 6, 2023 16:44 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 9,133 $0.40 $3,653.20
Disclosure

SEC source: 0001773751-23-000193 · wk-form4_1688676266.xml · nonDerivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 463,283

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

Read SEC document
July 03, 2023 Filed Jul 6, 2023 16:44 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 9,133 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-23-000193 · wk-form4_1688676266.xml · derivative · entry 5

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 859,953

Underlying: Class A Common Stock · 9,133 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
July 03, 2023 Filed Jul 6, 2023 16:44 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $9.19 $83,894.82
Disclosure

SEC source: 0001773751-23-000193 · wk-form4_1688676266.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 454,150

F1 · shares: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.085 - $9.44. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 03, 2023 Filed Jul 6, 2023 16:44 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 9,133 $0.40 $3,653.20
Disclosure

SEC source: 0001773751-23-000193 · wk-form4_1688676266.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 463,283

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 14 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 13

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28

Underlying: Class A Common Stock · 14 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F7 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after December 15, 2019.

F7 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after December 15, 2019.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 692 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 12

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,385

Underlying: Class A Common Stock · 692 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F7 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after December 15, 2019.

F7 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after December 15, 2019.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 4,763 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 11

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,290

Underlying: Class A Common Stock · 4,763 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020.

F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 94 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 10

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285

Underlying: Class A Common Stock · 94 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020.

F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 1,221 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 9

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,552

Underlying: Class A Common Stock · 1,221 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 1,625 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 8

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,380

Underlying: Class A Common Stock · 1,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 8,295 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 7

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,067

Underlying: Class A Common Stock · 8,295 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 48 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 6

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 340

Underlying: Class A Common Stock · 48 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 811 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 5

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,681

Underlying: Class A Common Stock · 811 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 18,712 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 4

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,839

Underlying: Class A Common Stock · 18,712 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 16,297 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 244,459

Underlying: Class A Common Stock · 16,297 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 20,682 $8.80 $182,001.60
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 454,150

F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 16:53 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 52,572 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 474,832

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 19:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 9,133 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-23-000161 · wk-form4_1686267077.xml · derivative · entry 6

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 869,086

Underlying: Class A Common Stock · 9,133 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 19:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $9.12 $83,260.99
Disclosure

SEC source: 0001773751-23-000161 · wk-form4_1686267077.xml · nonDerivative · entry 4

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 422,260

F2 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.955 - $9.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 19:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 9,133 $0.40 $3,653.20
Disclosure

SEC source: 0001773751-23-000161 · wk-form4_1686267077.xml · nonDerivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 431,393

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 19:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 2,481 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-23-000161 · wk-form4_1686267077.xml · derivative · entry 5

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 878,219

Underlying: Class A Common Stock · 2,481 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 19:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $9.08 $82,950.47
Disclosure

SEC source: 0001773751-23-000161 · wk-form4_1686267077.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 422,260

F2 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.88 - $9.205. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 19:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 2,481 $0.40 $992.40
Disclosure

SEC source: 0001773751-23-000161 · wk-form4_1686267077.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 431,393

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

Read SEC document
June 05, 2023 Filed Jun 7, 2023 17:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $8.89 $81,201.50
Disclosure

SEC source: 0001773751-23-000157 · wk-form4_1686173507.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 426,412

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.79 - $8.985. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 19, 2023 Filed Jun 7, 2023 17:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 OtherClass A Common Stock 2,500 $3.00 $7,500.00
Disclosure

SEC source: 0001773751-23-000157 · wk-form4_1686173507.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 428,912

F3 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the Purchase Period (as defined in the ESPP) of November 21, 2022 through May 20, 2023. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the issuer's common stock on May 23, 2022.

Read SEC document
May 10, 2023 Filed May 11, 2023 14:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 12,966 $0.40 Strike: $0.40 $5,186.40
Disclosure

SEC source: 0001773751-23-000131 · wf-form4_168382824358334.xml · derivative · entry 6

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 880,700

Underlying: Class A Common Stock · 12,966 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
May 10, 2023 Filed May 11, 2023 14:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 12,966 $0.40 $5,186.40
Disclosure

SEC source: 0001773751-23-000131 · wf-form4_168382824358334.xml · nonDerivative · entry 4

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 435,545

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

Read SEC document
May 09, 2023 Filed May 11, 2023 14:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 12,966 $0.40 Strike: $0.40 $5,186.40
Disclosure

SEC source: 0001773751-23-000131 · wf-form4_168382824358334.xml · derivative · entry 5

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 893,666

Underlying: Class A Common Stock · 12,966 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
May 09, 2023 Filed May 11, 2023 14:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $10.78 $98,496.67
Disclosure

SEC source: 0001773751-23-000131 · wf-form4_168382824358334.xml · nonDerivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 422,579

F2 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.52 - $11.425. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 09, 2023 Filed May 11, 2023 14:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 3,833 $10.78 $41,310.16
Disclosure

SEC source: 0001773751-23-000131 · wf-form4_168382824358334.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 431,712

F2 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.51 - $11.48. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 09, 2023 Filed May 11, 2023 14:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 12,966 $0.40 $5,186.40
Disclosure

SEC source: 0001773751-23-000131 · wf-form4_168382824358334.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 435,545

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

Read SEC document
May 08, 2023 Filed May 9, 2023 18:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 19,032 $0.40 $7,612.80
Disclosure

SEC source: 0001773751-23-000129 · wf-form4_168367054093060.xml · nonDerivative · entry 5

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 422,579

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · shares: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

Read SEC document
May 08, 2023 Filed May 9, 2023 18:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 3,833 $11.83 $45,335.57
Disclosure

SEC source: 0001773751-23-000129 · wf-form4_168367054093060.xml · nonDerivative · entry 4

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 403,547

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.73 - $12.00. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 08, 2023 Filed May 9, 2023 18:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $11.83 $108,013.25
Disclosure

SEC source: 0001773751-23-000129 · wf-form4_168367054093060.xml · nonDerivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 407,380

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.69 - $12.03. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 05, 2023 Filed May 9, 2023 18:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 19,032 $0.40 Strike: $0.40 $7,612.80
Disclosure

SEC source: 0001773751-23-000129 · wf-form4_168367054093060.xml · derivative · entry 6

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 906,632

Underlying: Class A Common Stock · 19,032 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
May 05, 2023 Filed May 9, 2023 18:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,899 $12.04 $119,182.97
Disclosure

SEC source: 0001773751-23-000129 · wf-form4_168367054093060.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 416,513

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.76 - $12.245. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 05, 2023 Filed May 9, 2023 18:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,133 $12.04 $109,950.36
Disclosure

SEC source: 0001773751-23-000129 · wf-form4_168367054093060.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 426,412

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.74 - $12.23. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.